MA53158A - Procédés de criblage et d'identification d'agents inhibant ou modulant le complexe de sortie nucléaire du virus de l'herpès - Google Patents

Procédés de criblage et d'identification d'agents inhibant ou modulant le complexe de sortie nucléaire du virus de l'herpès

Info

Publication number
MA53158A
MA53158A MA053158A MA53158A MA53158A MA 53158 A MA53158 A MA 53158A MA 053158 A MA053158 A MA 053158A MA 53158 A MA53158 A MA 53158A MA 53158 A MA53158 A MA 53158A
Authority
MA
Morocco
Prior art keywords
modulating
screening
methods
herpes virus
identifying agents
Prior art date
Application number
MA053158A
Other languages
English (en)
Inventor
Jutta Eichler
Manfred Marschall
Yves Muller
Heinrich Sticht
Original Assignee
Aicuris Gmbh & Co Kg
Univ Friedrich Alexander Er
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Gmbh & Co Kg, Univ Friedrich Alexander Er filed Critical Aicuris Gmbh & Co Kg
Publication of MA53158A publication Critical patent/MA53158A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/03—Herpetoviridae, e.g. pseudorabies virus
    • C07K14/04—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/03—Herpetoviridae, e.g. pseudorabies virus
    • C07K14/05—Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/04—Varicella-zoster virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/05—Epstein-Barr virus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
MA053158A 2018-07-20 2019-07-19 Procédés de criblage et d'identification d'agents inhibant ou modulant le complexe de sortie nucléaire du virus de l'herpès MA53158A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18184806 2018-07-20

Publications (1)

Publication Number Publication Date
MA53158A true MA53158A (fr) 2021-05-26

Family

ID=63014438

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053158A MA53158A (fr) 2018-07-20 2019-07-19 Procédés de criblage et d'identification d'agents inhibant ou modulant le complexe de sortie nucléaire du virus de l'herpès

Country Status (6)

Country Link
US (1) US20210396761A1 (fr)
EP (1) EP3823979A1 (fr)
AU (1) AU2019304526A1 (fr)
CA (1) CA3106833A1 (fr)
MA (1) MA53158A (fr)
WO (1) WO2020016433A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022029170A1 (fr) 2020-08-05 2022-02-10 Boehringer Ingelheim International Gmbh Difluorométhyl-pyridine-2-yl-triazoles

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
DE69120146T2 (de) 1990-01-12 1996-12-12 Cell Genesys Inc Erzeugung xenogener antikörper
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK0585287T3 (da) 1990-07-10 2000-04-17 Cambridge Antibody Tech Fremgangsmåde til fremstilling af specifikke bindingsparelementer
WO1993012227A1 (fr) 1991-12-17 1993-06-24 Genpharm International, Inc. Animaux transgeniques non humains capables de produire des anticorps heterologues
AU669489B2 (en) 1991-09-18 1996-06-13 Affymax Technologies N.V. Method of synthesizing diverse collections of oligomers
DE69333087T2 (de) 1992-10-01 2004-05-06 The Trustees Of Columbia University In The City Of New York Komplexe kombinatorische chemische banken, die mit markierungen versehen sind
CN1134156A (zh) 1993-11-02 1996-10-23 阿菲马克斯技术公司 合成和筛选多种分子
EP0758313A4 (fr) 1994-05-06 1999-09-15 Pharmacopeia Inc Bibliotheque combinatoire de dihydrobenzopyranes
US5663046A (en) 1994-06-22 1997-09-02 Pharmacopeia, Inc. Synthesis of combinatorial libraries
DK1135498T3 (da) * 1998-11-18 2008-05-26 Genentech Inc Antistofvarianter med höjere bindingsaffinitet end forældreantistoffer
US6818418B1 (en) * 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
CA2645507A1 (fr) * 2006-03-10 2007-09-20 The Regents Of The University Of California Vaccins pour des virus provoquant des infections persistantes ou latentes
EA201270662A1 (ru) * 2009-12-23 2013-01-30 4-Антибоди Аг Связывающие элементы для человеческого цитамегаловируса
JP2016501023A (ja) * 2012-12-04 2016-01-18 メルク・シャープ・アンド・ドーム・コーポレーションＭ 条件付き複製ウイルスベクター
US20150051090A1 (en) * 2013-08-19 2015-02-19 D.E. Shaw Research, Llc Methods for in silico screening
AU2017235361A1 (en) * 2016-03-14 2018-10-04 Redbiotec Ag Means and methods for treating HSV
CN112512566A (zh) * 2018-04-03 2021-03-16 赛诺菲 抗原性爱泼斯坦-巴尔病毒多肽

Also Published As

Publication number Publication date
WO2020016433A1 (fr) 2020-01-23
AU2019304526A1 (en) 2020-12-24
EP3823979A1 (fr) 2021-05-26
US20210396761A1 (en) 2021-12-23
CA3106833A1 (fr) 2020-01-23

Similar Documents

Publication Publication Date Title
MA50948A (fr) Anticorps et procédés d'utilisation de ceux-ci
MA45595A (fr) Protéines de liaison au ligand (1) de mort programmée (1) (pd-l1) et leurs procédés d'utilisation
MA55890A (fr) Modulateurs de thr-beta et leurs procédés d'utilisation
MA46200A (fr) Procédés d'utilisation d'un anticorps bispécifique qui reconnaît le facteur de coagulation ix et/ou le facteur de coagulation ix activé et le facteur de coagulation x et/ou le facteur de coagulation x activé
MA42043A (fr) Anticorps anti-ox40 et procédés d'utilisation de ceux-ci
MA44524A (fr) Néoantigènes et leurs procédés d'utilisation
MA55628A (fr) Agents de dégradation tricycliques d'ikaros et d'aiolos
WO2016069591A9 (fr) Compositions, procédés et utilisation de criblage létal synthétique
MY191926A (en) Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging
MA53235A (fr) Indoles substitués et procédés d'utilisation associés
MA50956A (fr) Anticorps anti-cd137 et procédés d'utilisation correspondants
MA55301A (fr) Inhibiteurs de protéine tyrosine phosphatase et leurs procédés d'utilisation
MA56121A (fr) Procédés d'identification d'attributs de protéines thérapeutiques
MA49512A (fr) Protéines de liaison à l'antigène anti-papillomavirus humain et leurs méthodés d'utilisation
MA52963A (fr) Inhibiteurs de protéine tyrosine phosphatase et leurs procédés d'utilisation
MA53727A (fr) Copolymères séquencés de polycarbonate et procédés associés
MA46844A (fr) Protéines de liaison à un antigène anti-gitr et leurs procédés d'utilisation
IL281014A (en) Detection and documentation of speeding violations
MA52797A (fr) Inhibiteurs de masp -2 et procédés d'utilisation
MA50196A (fr) Récipient d'approvisionnement de développateur et système d'approvisionnement de développateur
MA56457A (fr) Modulateurs de hsd17b13 et leurs procédés d'utilisation
MA50433A (fr) Protéines à greffe de cytokine-anticorps et procédés d'utilisation contre des troubles liés à l'immunité
MA54909A (fr) Procédés et appareil de traitement d'eau
DE112019002645A5 (de) Warnung vor und absicherung von gefahrenstellen durch fahrzeuge
FR3046250B1 (fr) Procede de determination de la direction d'arrivee en presence de repliement spectral et dispositif associe